Equine Diagnostic Services - Global Strategic Business Report

The global market for Equine Diagnostic Services was valued at US$800.4 Million in 2024 and is projected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Equine Diagnostic Services market.

Global Equine Diagnostic Services Market - Key Trends & Drivers Summarized

How Are Diagnostic Services Enhancing Equine Healthcare and Performance Monitoring?

Equine diagnostic services support the detection, evaluation, and management of diseases, injuries, and performance issues in horses. These services include laboratory tests, imaging techniques, and physiological assessments that help veterinarians and equine caretakers maintain the health, productivity, and athletic readiness of horses. Diagnostic tools play a critical role in early intervention, especially for conditions that may not present visible symptoms until advanced stages.

Commonly offered diagnostics include blood profiles, fecal tests, joint fluid analysis, reproductive evaluations, and advanced imaging such as ultrasound, radiography, and endoscopy. These services are vital in detecting lameness, respiratory conditions, gastrointestinal issues, and infectious diseases. For competitive and breeding horses, diagnostics help assess fertility, monitor training impact, and prevent performance-related injuries. The increasing value placed on equine welfare and sports integrity is pushing demand for regular and accurate diagnostic testing.

What Innovations Are Advancing the Accuracy and Scope of Equine Diagnostics?

The field of equine diagnostics is benefitting from advances in imaging, molecular biology, and point-of-care testing. Digital radiography and portable ultrasound systems are allowing for faster, more detailed imaging at stables and race venues. Endoscopy is being used more frequently for respiratory and gastrointestinal tract assessment, particularly in performance horses. Wearable health monitors and gait analysis tools are emerging to support real-time movement tracking and biomechanical evaluation.

Laboratories are offering more refined blood and genetic testing, including hormonal assays, disease-specific markers, and hereditary condition screening. PCR-based assays are improving early detection of infectious diseases, while real-time biochemical analyzers are supporting faster turnaround in emergency settings. Mobile diagnostic units and digital platforms are expanding access to remote or rural locations, making it easier for veterinarians to offer advanced diagnostics at the point of care.

Which Segments and Stakeholders Are Fueling Diagnostic Service Adoption?

Racehorses, show jumpers, and breeding stock represent the highest demand segments for diagnostic services due to the high economic and reputational value of these animals. Owners, trainers, breeders, and equine veterinarians are primary stakeholders seeking data-driven tools to optimize health management and prevent losses. Large equine clinics, veterinary universities, and specialized labs form the core service providers, with many offering subscription-based or routine diagnostic packages.

In addition to elite horses, there is growing interest in diagnostics for recreational and therapy horses, driven by greater attention to animal welfare and preventive care. Insurance companies and regulatory bodies are also playing a role by mandating diagnostic tests for coverage eligibility and competition clearance. As awareness of zoonotic disease risks increases, early detection of equine pathogens is being prioritized in herd management and biosecurity planning.

What Is Driving Growth in the Equine Diagnostic Services Market?

Growth in the equine diagnostic services market is driven by several factors related to veterinary innovation, performance monitoring, and animal health prioritization. Rising demand for early and accurate disease detection is leading to greater reliance on laboratory and imaging-based diagnostics. The high commercial value of performance horses is prompting regular testing for injury prevention, fertility assessment, and fitness optimization.

Technological advances in portable diagnostics, digital imaging, and genetic screening are making sophisticated services more accessible across diverse equine populations. Broader availability of mobile labs and online service platforms is enabling diagnostics in remote or underserved areas. Regulatory oversight in sports and rising interest in equine health insurance are further supporting structured diagnostic routines. These dynamics are contributing to sustained adoption of professional diagnostic services in equine care and performance management.

Scope of the Report

The report analyzes the Equine Diagnostic Services market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below:

• Segments: Service (Computed Tomography Service, X-ray Service, Ultrasound Service, Endoscopy Service, Magnetic Resonance Imaging Service, Other Services); Application (Orthopedics & Traumatology Application, Oncology Application, Cardiology Application, Neurology Application, Respiratory Application, Dental Application, Other Applications); Service Provider (Veterinary Clinics & Hospitals Service Provider, Academics & Research Institutes Service Provider, Other Service Providers).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Computed Tomography Service segment, which is expected to reach US$324.9 Million by 2030 with a CAGR of a 8.1%. The X-ray Service segment is also set to grow at 4.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $218.1 Million in 2024, and China, forecasted to grow at an impressive 10.5% CAGR to reach $244.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Equine Diagnostic Services Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Equine Diagnostic Services Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Equine Diagnostic Services Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abaxis (part of Zoetis), Animal Genetics Inc., B&W Equine Vets, Bio-Rad Laboratories, Inc., Ceva Santé Animale and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Equine Diagnostic Services market report include:

• Abaxis (part of Zoetis)
• Animal Genetics Inc.
• B&W Equine Vets
• Bio-Rad Laboratories, Inc.
• Ceva Santé Animale
• Dechra Pharmaceuticals PLC
• EDS (Equine Diagnostic Solutions, LLC)
• EquiSeq Inc.
• Generatio GmbH
• Hagyard Equine Medical Institute
• Heska Corporation
• IDEXX Laboratories, Inc.
• IMV Imaging (Part of IMV Technologies)
• Neogen Corporation
• National Research Centre on Equines (NRCE)
• Randox Laboratories Ltd.
• Texas A&M Veterinary Medical Diagnostic Lab
• Thermo Fisher Scientific Inc.
• UC Davis Veterinary Genetics Laboratory (VGL)
• VetGen

This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis from 2015 to 2023.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025 (E), competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.